Bank of America Reports First Quarter 2025 Financial Results
CHARLOTTE, N.C., April 15, 2025 /PRNewswire/ -- Bank of America reported its…
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
April 14, 2025 16:05 ET | Source: IRIDEX Corporation MOUNTAIN VIEW, Calif.,…
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results
KIRKLAND, Wash., April 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.…
Bel Fuse Schedules First Quarter 2025 Financial Results Conference Call
April 11, 2025 15:27 ET | Source: Bel Fuse Inc. WEST ORANGE,…
Signing Day Sports Announces Selected Financial Results for the Year Ended December 31, 2024
SCOTTSDALE, Ariz., April 11, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc.…
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2024 Financial Results on April 14, 2025
April 11, 2025 18:15 ET | Source: TOMI Environmental Solutions, Inc. FREDERICK,…
Innventure Reports Fourth Quarter and Full Year 2024 Results
Accelsius and AeroFlexx started generating revenue with expectations to grow in 2025…
Byrna Technologies Fiscal First Quarter 2025 Results
ANDOVER, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna”…
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
April 07, 2025 17:10 ET | Source: Merit Medical Systems, Inc. SOUTH…
iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody,…